Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-24

Clinical Trial Update: Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath

View source ↗

Summary

A clinical trial sponsored by ChromX Health is evaluating whether volatile organic compounds in human exhaled breath can differentiate benign from malignant pul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: ChromX Health | Conditions: Pulmonary Nodules, Multiple, Pulmonary Nodules, Solitary | Status: RECRUITING